FIGURE

Fig. 10

ID

ZDB-FIG-210902-106

Publication

Jia et al., 2021 - FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells

Other Figures

All Figure Page

Back to All Figure Page

Fig. 10

sVEGFR1-ex12 is a poor prognosis marker in squamous lung carcinoma patients. a, b Different sVEGFR1-exon12 usage value (exon expression value divided by gene expression value) between squamous lung carcinoma patients displaying low (<median, 1st and 2nd quartiles, n=243) and high (≥median, 3rd and 4th quartiles, n=244) FGF-2 (a) or FGFR1 (b) mRNA levels. Data is presented with mean ± SD. p values were calculated with an unpaired t test, ***p<0.001. c Overall survival analysis stratified according to sVEGFR1-exon12 usage value in squamous lung carcinoma patients for who clinical annotations were available (n=411). Low indicates the value below the median level (n=205) and high indicates values above the median level (n=206). The p value was calculated using a log-rank test

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ BMC Biol.